Lv5
1090 积分 2021-12-01 加入
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumors
3个月前
已完结
Inflammatory age and its impact on age-related health in older Chinese adults
4个月前
已完结
Dinutuximab beta in high-risk neuroblastoma: a profile of its use
4个月前
已完结
Degrader-antibody conjugates
5个月前
已完结
Degrader–Antibody Conjugates: Emerging New Modality
5个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
5个月前
已完结
Methylenedioxymethamphetamine (MDMA) in Psychiatry
6个月前
已关闭
Neurological and cognitive alterations induced by MDMA in humans
6个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
6个月前
已完结
Is lirentelimab the ‘magic bullet’ to fight pathological mast-cell activation in systemic mastocytosis?
6个月前
已完结
皖公网安备34019202002308
